Eckert & Ziegler SE (EUZ.DE)
- Previous Close
60.35 - Open
60.35 - Bid 60.80 x 3800
- Ask 61.00 x 82100
- Day's Range
60.35 - 61.25 - 52 Week Range
36.80 - 62.05 - Volume
8,101 - Avg. Volume
44,580 - Market Cap (intraday)
1.272B - Beta (5Y Monthly) 1.58
- PE Ratio (TTM)
31.94 - EPS (TTM)
1.91 - Earnings Date May 13, 2025
- Forward Dividend & Yield 0.50 (0.83%)
- Ex-Dividend Date Jun 19, 2025
- 1y Target Est
66.00
Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration related sources for radioisotopes. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.
www.ezag.comRecent News: EUZ.DE
View More
Performance Overview: EUZ.DE
Trailing total returns as of 5/5/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EUZ.DE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EUZ.DE
View MoreValuation Measures
Market Cap
1.26B
Enterprise Value
1.20B
Trailing P/E
31.60
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.26
Price/Book (mrq)
5.63
Enterprise Value/Revenue
4.04
Enterprise Value/EBITDA
14.76
Financial Highlights
Profitability and Income Statement
Profit Margin
11.25%
Return on Assets (ttm)
9.44%
Return on Equity (ttm)
18.19%
Revenue (ttm)
295.85M
Net Income Avi to Common (ttm)
40.04M
Diluted EPS (ttm)
1.91
Balance Sheet and Cash Flow
Total Cash (mrq)
118.36M
Total Debt/Equity (mrq)
24.57%
Levered Free Cash Flow (ttm)
84.93M